RGEBX
Price
$83.64
Change
+$0.75 (+0.90%)
Updated
Aug 21 closing price
Net Assets
342.42B
SPECX
Price
$36.81
Change
+$0.13 (+0.35%)
Updated
Aug 21 closing price
Net Assets
4.44B
Interact to see
Advertisement

RGEBX vs SPECX

RGEBX vs SPECX Comparison Chart in %
View a ticker or compare two or three
VS
RGEBX vs. SPECX commentary
Aug 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGEBX is a StrongBuy and SPECX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 342B vs. SPECX (4.44B). RGEBX (0.00) and SPECX (0.00) have matching dividends . RGEBX was incepted earlier than SPECX: RGEBX (12 years) vs SPECX (57 years). SPECX (1.53) is less costly to investors than RGEBX (1.08). SPECX is a more actively managed with annual turnover of: 51.13 vs. RGEBX (32.00). RGEBX has a lower initial minimum investment than SPECX: RGEBX (250) vs SPECX (1000). SPECX annual gain was more profitable for investors over the last year : 10.94 vs. RGEBX (4.65). RGEBX return over 5 years is better than : 13.60 vs. SPECX (12.71).
RGEBXSPECXRGEBX / SPECX
Total Expense Ratio1.081.5371%
Annual Report Gross Expense Ratio1.081.5371%
Fund Existence12 years57 years-
Gain YTD9.1057.789117%
Front LoadN/A5%-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets342B4.44B7,710%
Annual Yield % from dividends0.000.00-
Returns for 1 year4.6510.9443%
Returns for 3 years43.99100.7144%
Returns for 5 years13.6012.71107%
Returns for 10 years92.84112.2883%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ULBI7.010.16
+2.34%
Ultralife Corp
CLGN0.31N/A
+0.29%
CollPlant Biotechnologies Ltd
KEY21.870.02
+0.09%
KeyCorp
USLM118.89-1.25
-1.04%
United States Lime & Minerals
RGNX10.72-0.34
-3.07%
REGENXBIO